Consistent with previous reports, CCR8 is hyperexpressed on Tregs, and its ligand, CCL4, secreted by M2 macrophages, has been demonstrated to recruit Tregs to the tumor niche in other cancers [48, 49]. The gene discussed is CCL4; the disease is cancer.